These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 31779983)

  • 1. Does early diagnosis and treatment of myelodysplastic syndromes make a difference?
    Steensma DP
    Best Pract Res Clin Haematol; 2019 Dec; 32(4):101099. PubMed ID: 31779983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis and Treatment of Myelodysplastic Syndromes: A Review.
    Sekeres MA; Taylor J
    JAMA; 2022 Sep; 328(9):872-880. PubMed ID: 36066514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of myelodysplastic syndromes: 2008 update.
    Scott BL; Estey E
    Oncology (Williston Park); 2008 Nov; 22(12):1344-52. PubMed ID: 19086598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel therapies in low- and high-risk myelodysplastic syndrome.
    Germing U; Schroeder T; Kaivers J; Kündgen A; Kobbe G; Gattermann N
    Expert Rev Hematol; 2019 Oct; 12(10):893-908. PubMed ID: 31353975
    [No Abstract]   [Full Text] [Related]  

  • 5. Selection of patients with myelodysplastic syndromes from a large electronic medical records database and a study of the use of disease-modifying therapy in the United States.
    Ma X; Steensma DP; Scott BL; Kiselev P; Sugrue MM; Swern AS
    BMJ Open; 2018 Jul; 8(7):e019955. PubMed ID: 30037860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myelodysplastic syndromes: 2015 Update on diagnosis, risk-stratification and management.
    Garcia-Manero G
    Am J Hematol; 2015 Sep; 90(9):831-41. PubMed ID: 26294090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New Approaches to Myelodysplastic Syndrome Treatment.
    Bazinet A; Bravo GM
    Curr Treat Options Oncol; 2022 May; 23(5):668-687. PubMed ID: 35320468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In MDS, is higher risk higher reward?
    Sanz GF
    Hematology Am Soc Hematol Educ Program; 2019 Dec; 2019(1):381-390. PubMed ID: 31808894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. British Society for Haematology guidelines for the management of adult myelodysplastic syndromes.
    Killick SB; Ingram W; Culligan D; Enright H; Kell J; Payne EM; Krishnamurthy P; Kulasekararaj A; Raghavan M; Stanworth SJ; Green S; Mufti G; Quek L; Cargo C; Jones GL; Mills J; Sternberg A; Wiseman DH; Bowen D
    Br J Haematol; 2021 Jul; 194(2):267-281. PubMed ID: 34180045
    [No Abstract]   [Full Text] [Related]  

  • 10. Improving Treatment for Myelodysplastic Syndromes Patients.
    Montoro J; Yerlikaya A; Ali A; Raza A
    Curr Treat Options Oncol; 2018 Oct; 19(12):66. PubMed ID: 30362079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal sequencing of treatments for patients with myelodysplastic syndromes.
    Itzykson R; Fenaux P
    Curr Opin Hematol; 2009 Mar; 16(2):77-83. PubMed ID: 19468268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early treatment initiation in lower-risk myelodysplastic syndromes produces an earlier and higher rate of transfusion independence.
    Cogle CR; Reddy SR; Chang E; Papoyan E; Broder MS; McGuire M; Binder G
    Leuk Res; 2017 Sep; 60():123-128. PubMed ID: 28818807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment for low-risk myelodysplastic syndromes].
    Morita Y
    Rinsho Ketsueki; 2018; 59(10):2050-2057. PubMed ID: 30305508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can Lower-Risk MDS Achieve High Reward with Hypomethylating Agent Therapy?
    Bejar R
    NEJM Evid; 2022 Oct; 1(10):EVIDe2200165. PubMed ID: 38319862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypomethylating agents for patients with myelodysplastic syndromes prior to hematopoietic stem cell transplantation: a systematic review and meta-analysis.
    Qin Y; Kuang P; Zeng Q; Wu Y; Liu T
    Ann Hematol; 2019 Nov; 98(11):2523-2531. PubMed ID: 31637485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myelodysplastic syndromes.
    Scott BL; Deeg HJ
    Annu Rev Med; 2010; 61():345-58. PubMed ID: 20059342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myelodysplastic Syndromes: Diagnosis and Treatment.
    Steensma DP
    Mayo Clin Proc; 2015 Jul; 90(7):969-83. PubMed ID: 26141335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of higher risk myelodysplastic syndromes].
    Usuki K
    Rinsho Ketsueki; 2019; 60(9):1131-1139. PubMed ID: 31597836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myelodysplastic syndromes: introduction.
    Sloand EM
    Semin Hematol; 2008 Jan; 45(1):1-2. PubMed ID: 18179962
    [No Abstract]   [Full Text] [Related]  

  • 20. Myelodysplastic syndromes: Contemporary review and how we treat.
    Gangat N; Patnaik MM; Tefferi A
    Am J Hematol; 2016 Jan; 91(1):76-89. PubMed ID: 26769228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.